Cite

    Tahmaz, V. et al. (2017). Treatment of severe chronic ocular graft-versus-host disease using 100% autologous serum eye drops from a sealed manufacturing system: a retrospective cohort study. British journal of ophthalmology. 101 (3), pp. 322-326. [Online].